Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Forma Therapeutics Inc patents

Recent patent applications related to Forma Therapeutics Inc. Forma Therapeutics Inc is listed as an Agent/Assignee. Note: Forma Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Forma Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "F" | Forma Therapeutics Inc-related inventors

Novel compounds and compositions for inhibition of fasn

The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below:... Forma Therapeutics Inc

Alpha-cinnamide compounds and compositions as hdac8 inhibitors

The present invention relates to inhibitors of histone deacetylases, in particular HDAC8, that are useful for the treatment of cancer and other diseases and disorders, as well as the synthesis and applications of said inhibitors.... Forma Therapeutics Inc

Methods of using fasn inhibitors

The present disclosure relates to methods of treating, preventing or ameliorating a TH17- or CSF1-mediated disease or disorder such as cancer, immunological disorders, and obesity by administering to a patient in need thereof a therapeutically effective amount of a FASN inhibitor, or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer,... Forma Therapeutics Inc

Pyridin-2(1h)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

where A, U, W1, W2, W3, R1-R6, and R9 are described herein.... Forma Therapeutics Inc

Purinones as ubiquitin-specific protease 1 inhibitors

where R1, R2, R3, R3′, R4, R5, X1, X2, X3, X4, and n are described herein.... Forma Therapeutics Inc

[6,6] fused bicyclic hdac8 inhibitors

and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, tautomers, or isomers or thereof, wherein R1, R2, R2′, L, X, W, Y1, Y2, Y3, and Y4 are described herein.... Forma Therapeutics Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Forma Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Forma Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by